172 related articles for article (PubMed ID: 28318631)
1. The antihelmenthic phosphate niclosamide impedes renal fibrosis by inhibiting homeodomain-interacting protein kinase 2 expression.
Chang X; Zhen X; Liu J; Ren X; Hu Z; Zhou Z; Zhu F; Ding K; Nie J
Kidney Int; 2017 Sep; 92(3):612-624. PubMed ID: 28318631
[TBL] [Abstract][Full Text] [Related]
2. A Novel Inhibitor of Homeodomain Interacting Protein Kinase 2 Mitigates Kidney Fibrosis through Inhibition of the TGF-
Liu R; Das B; Xiao W; Li Z; Li H; Lee K; He JC
J Am Soc Nephrol; 2017 Jul; 28(7):2133-2143. PubMed ID: 28220029
[TBL] [Abstract][Full Text] [Related]
3. A systems approach identifies HIPK2 as a key regulator of kidney fibrosis.
Jin Y; Ratnam K; Chuang PY; Fan Y; Zhong Y; Dai Y; Mazloom AR; Chen EY; D'Agati V; Xiong H; Ross MJ; Chen N; Ma'ayan A; He JC
Nat Med; 2012 Mar; 18(4):580-8. PubMed ID: 22406746
[TBL] [Abstract][Full Text] [Related]
4. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
[TBL] [Abstract][Full Text] [Related]
5. Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-β/Smad and NF-κB signaling pathway in 5/6 nephrectomized rats.
Wang DT; Huang RH; Cheng X; Zhang ZH; Yang YJ; Lin X
Int Immunopharmacol; 2015 May; 26(1):4-12. PubMed ID: 25744602
[TBL] [Abstract][Full Text] [Related]
6. Niclosamide alleviates pulmonary fibrosis in vitro and in vivo by attenuation of epithelial-to-mesenchymal transition, matrix proteins & Wnt/β-catenin signaling: A drug repurposing study.
Boyapally R; Pulivendala G; Bale S; Godugu C
Life Sci; 2019 Mar; 220():8-20. PubMed ID: 30611787
[TBL] [Abstract][Full Text] [Related]
7. Niclosamide-loaded polymeric micelles ameliorate hepatocellular carcinoma in vivo through targeting Wnt and Notch pathways.
Zeyada MS; Abdel-Rahman N; El-Karef A; Yahia S; El-Sherbiny IM; Eissa LA
Life Sci; 2020 Nov; 261():118458. PubMed ID: 32961231
[TBL] [Abstract][Full Text] [Related]
8. TGF-β/Smad signaling in kidney disease.
Lan HY; Chung AC
Semin Nephrol; 2012 May; 32(3):236-43. PubMed ID: 22835454
[TBL] [Abstract][Full Text] [Related]
9. Low-dose of multi-glycoside of Tripterygium wilfordii Hook. f., a natural regulator of TGF-β1/Smad signaling activity improves adriamycin-induced glomerulosclerosis in vivo.
Wan YG; Che XY; Sun W; Huang YR; Meng XJ; Chen HL; Shi XM; Tu Y; Wu W; Liu YL
J Ethnopharmacol; 2014 Feb; 151(3):1079-1089. PubMed ID: 24362077
[TBL] [Abstract][Full Text] [Related]
10. Novel RAS Inhibitors Poricoic Acid ZG and Poricoic Acid ZH Attenuate Renal Fibrosis via a Wnt/β-Catenin Pathway and Targeted Phosphorylation of smad3 Signaling.
Wang M; Chen DQ; Chen L; Liu D; Zhao H; Zhang ZH; Vaziri ND; Guo Y; Zhao YY; Cao G
J Agric Food Chem; 2018 Feb; 66(8):1828-1842. PubMed ID: 29383936
[TBL] [Abstract][Full Text] [Related]
11. Tubular HIPK2 is a key contributor to renal fibrosis.
Xiao W; E J; Bao L; Fan Y; Jin Y; Wang A; Bauman D; Li Z; Zheng YL; Liu R; Lee K; He JC
JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32701510
[TBL] [Abstract][Full Text] [Related]
12. Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species.
Jin Y; Lu Z; Ding K; Li J; Du X; Chen C; Sun X; Wu Y; Zhou J; Pan J
Cancer Res; 2010 Mar; 70(6):2516-27. PubMed ID: 20215516
[TBL] [Abstract][Full Text] [Related]
13. Ureic clearance granule, alleviates renal dysfunction and tubulointerstitial fibrosis by promoting extracellular matrix degradation in renal failure rats, compared with enalapril.
Huang YR; Wei QX; Wan YG; Sun W; Mao ZM; Chen HL; Meng XJ; Shi XM; Tu Y; Zhu Q
J Ethnopharmacol; 2014 Sep; 155(3):1541-52. PubMed ID: 25087615
[TBL] [Abstract][Full Text] [Related]
14. Rhodojaponin II attenuates kidney injury by regulating TGF-β1/Smad pathway in mice with adriamycin nephropathy.
Qiu Y; Zhou J; Zhang H; Zhou H; Tang H; Lei C; Ye C; You C; Chen Y; Wang Y; Xiong J; Su H; Yao G; Zhang C
J Ethnopharmacol; 2019 Oct; 243():112078. PubMed ID: 31301369
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting aerobic glycolysis suppresses renal interstitial fibroblast activation and renal fibrosis.
Ding H; Jiang L; Xu J; Bai F; Zhou Y; Yuan Q; Luo J; Zen K; Yang J
Am J Physiol Renal Physiol; 2017 Sep; 313(3):F561-F575. PubMed ID: 28228400
[TBL] [Abstract][Full Text] [Related]
16. The ameliorative effect of niclosamide on bile duct ligation induced liver fibrosis via suppression of NOTCH and Wnt pathways.
Esmail MM; Saeed NM; Michel HE; El-Naga RN
Toxicol Lett; 2021 Sep; 347():23-35. PubMed ID: 33961984
[TBL] [Abstract][Full Text] [Related]
17. Nintedanib, a triple tyrosine kinase inhibitor, attenuates renal fibrosis in chronic kidney disease.
Liu F; Wang L; Qi H; Wang J; Wang Y; Jiang W; Xu L; Liu N; Zhuang S
Clin Sci (Lond); 2017 Aug; 131(16):2125-2143. PubMed ID: 28646122
[TBL] [Abstract][Full Text] [Related]
18. HIPK2 C-terminal domain inhibits NF-κB signaling and renal inflammation in kidney injury.
Feng Y; Li Z; Wang H; Liu BC; Lee K; He JC
JCI Insight; 2024 Mar; 9(8):. PubMed ID: 38512421
[TBL] [Abstract][Full Text] [Related]
19. Niclosamide, an old antihelminthic agent, demonstrates antitumor activity by blocking multiple signaling pathways of cancer stem cells.
Pan JX; Ding K; Wang CY
Chin J Cancer; 2012 Apr; 31(4):178-84. PubMed ID: 22237038
[TBL] [Abstract][Full Text] [Related]
20. EGFR drives the progression of AKI to CKD through HIPK2 overexpression.
Xu L; Li X; Zhang F; Wu L; Dong Z; Zhang D
Theranostics; 2019; 9(9):2712-2726. PubMed ID: 31131063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
